Advances in novel drug delivery strategies for breast cancer therapy

Ritu Dhankhar, Suresh P. Vyas, Arvind K. Jain, Sahil Arora, Goutam Rath, Amit K. Goyal

Research output: Contribution to journalArticlepeer-review

86 Scopus citations


Breast cancer remains one of the world's most devastating diseases. However, better understanding of tumor biology and improved diagnostic devices could lead to improved therapeutic outcomes. Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Various nanocarriers have been introduced to improve the therapeutic efficacy of anticancer drugs, including liposomes, polymeric micelles, quantum dots, nanoparticles, and dendrimers. Recently, targeted drug delivery systems for anti-tumor drugs have demonstrated great potential to lower cytotoxicity and increase therapeutic effects. Various ligands/approaches have been explored for targeting breast cancer. This paper provides an overview of breast cancer, conventional therapy, potential of nanotechnology in management of breast cancer, and rational approaches for targeting breast cancer. © 2010 Informa Healthcare USA, Inc.
Original languageEnglish (US)
Pages (from-to)230-249
Number of pages20
JournalArtificial Cells, Blood Substitutes, and Biotechnology
Issue number5
StatePublished - Oct 1 2010
Externally publishedYes

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biotechnology


Dive into the research topics of 'Advances in novel drug delivery strategies for breast cancer therapy'. Together they form a unique fingerprint.

Cite this